Authors: Pierre-Yves Bondiau1, Stephanie Bolle2, Alexandre Escande3,4,5, Loig Duverge6, Charlotte Demoor7,8, Angela Rouyar-Nicolas2, Basile Bertrand9, Arthus Cannard9, Leo Hardy9, Catherine Martineau-Huynh10, Nikos Paragios9,11, Thais Roque10, Eric Deutsch2, Charlotte Robert2
1IMPT, Centre Antoine Lacassagne, Radiation Oncology , Nice, France; 2Gustave Roussy Cancer Campus, Department of Radiation Oncology, Villejuif, France; 3Oscar Lambret Comprehensive Cancer Center, Department of Radiation Oncology, Lille, France; 4H.Warembourg School of medicine, University of Lille, School of Medicine, Lille, France; 5University of Lille, CRIStAL Laboratory, UMR 9189,, Lille, France; 6Eugène Marquis Comprehensive Cancer Center, Department of Radiation Oncology, Rennes, France; 7Centre François Baclesse, Radiotherapy department, Caen, France; 8CHU Angers, Pediatric Oncology, Angers, France; 9TheraPanacea, Research and Development, Paris, France; 10TheraPanacea, Clinical and Partnerships Affairs, Paris, France; 11CentraleSupelec, University of Paris-Saclay, Computer Science and Applied Mathematics, Gif-sur-Yvette, France